Indications
Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1-infected patients (adults and children of two years of age and older).
Composition
- Active substance
- ritonavir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Norvir
- Active substance
- ritonavir
- ATC code
- J05AE03
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- AbbVie Deutschland GmbH & Co. KG
- Status
- Authorised
- EU authorisation
- 25 Aug 1996